That's important, since the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. Simply put, we need to understand how these proteins fold if we want a drug to work. Historically, this has actually been an experimental procedure (jeff brown biotech stock). However now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're designed to do. This was a development practically no one noticed. But it's going to have profound implications for curing illness. I forecast that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be lots of investment opportunities in this area, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (melania trump). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be surprised if it drew back possibly significantly prior to going higher - jeff brown investment prediction. I have actually been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. However that's not the huge concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, specific niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So consider that. In five years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. diplomatic relations. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward prediction 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are many terrific personal business on the brink of hitting the general public markets And I have actually been working on a brand-new way for you to invest even before these business go public.
This opportunity has been building over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to book your spot free of charge.
Emma Walsh here, managing editor of the Journal. Routine Journal readers understand that tech isn't our normal beat (jeff brown prediction for 2021). And when it pertains to tech investing, we leave it to the professionals. Fortunately, we have several such professionals in our Rolodex. Our coworker Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing specialists we know (second wave). In fact, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the big image and forecast what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and far more. These patterns are experiencing exponential growth and producing extraordinary opportunities for financiers. I desire to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. biotech stock. However in spite of what lots of readers may believe, this is a pattern that's simply starting. Despite the fact that the COVID-19 pandemic disrupted supply chains last year, a remarkable 250 million 5G-enabled gadgets were still offered.
And all of this eventually caused Apple postponing the release of the 5G-enabled i, Phone 12 by two months (toxic tech 5 tech darlings). Losing two months of production and sales actually impacts how numerous 5G devices are sold in the fiscal year. When you think about all of that, offering 250 million units is exceptional. More significantly, the hold-ups caused by the pandemic created a lots of suppressed demand. And that need is now going to be pressed into 2021. In truth, I predict that more than 500 million 5G devices will be shipped in 2021 - korean actress. And that's not my only 5G forecast When I've discussed 5G in the past, I have actually described its 3 various phases.
In Phase Two, 5G devices go on sale. 5G phones and other items begin to reach customers. And in Phase 3, 5G services begin to be provided (second wave). That's when we begin to see applications running on 5G networks. Think about things like enormous multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will start Stage Three by this summer season. This starts something of a virtuous cycle: The majority of people do not actually appreciate the technology. However they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open a suite of extraordinary applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment chances moving forward will be huge. Stepping far from 5G, the next important technology I foresee in 2021 is CRISPR hereditary modifying. CRISPR represents "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software.
The program can crash or not operate correctly. CRISPR utilizes a comparable idea however with our hereditary code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For many years, CRISPR was primarily a niche technology that wasn't well comprehended. And throughout that time, there were actually only 3 business operating in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing actual outcomes. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR business is going public and delivering incredible returns. This entire industry is successfully a greenfield opportunity.
There's room for lots of business to exist in this space. self-driving cars. And there will be more. That's my forecast for CRISPR in 2021. I forecast that two or 3 more genetic editing business will hold their IPOs. Sticking with biotechnology, we are seeing incredible things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software can precisely forecast the folding of a protein based entirely on its amino acid series with 92. 4% precision. That's essential since the way a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but a number of drug therapies produced utilizing this innovation. This was among those developments that nearly no one saw. However it's going to have extensive ramifications for treating illness. And, of course, there will be plenty of investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be shocked if it pulled back maybe considerably prior to going higher. I have actually been covering bitcoin for a long time now. Among the first research reports I ever published was on bitcoin - brownstone research. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche business. genetic sequencer stock jeff brown. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the info is up to date as of February 2021, however we might not independently validate this claim. Given Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to select winning innovation stocks. He spent more than 25 years investigating technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an excellent point of view on the market. He's always on the hunt for brand-new opportunities, and he shares many of his finest picks in the Near Future Report.
That's high appreciation, however it's not absurdly reasoned. Brown has an exceptional track record as a stock-picker, and he successfully forecasted some of the most significant economic events of the previous 20 years. Although he doesn't appear to release his picks to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal each time, but Jeff Brown's accurate forecasts have actually made him legions of dedicated followers. That states a lot about his ability. The Near Future Report is released by Brownstone Research study, a popular financial research study publisher. Brownstone Research provides several research study services with a wide variety of expertises - melania trump.
The business is likewise connected with Bonner & Partners, another well-respected research study publisher - social media. On its website, Brownstone states its mission is to supply retail investors with professional-grade research: "For too long, the very best financial investment research study has not been available to specific investors. It has actually been typically scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. biotech stocks jeff brown. The mission of Brownstone Research study is to make that type of exclusive research readily available to any financiers aiming to gain an edge in the marketplaces. The objective is easy to provide unique and profitable investment research found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research, and he also works as the firm's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to use its clients. After years of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you understand even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. jeff brown prediction for 2021. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive expertise, so he always has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big job.
In reality, Brown believes S.A.V. artificial intelligence. could be "the most significant pattern of the 2020s, and he's not alone. Check out these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two innovative innovations: expert system and electric cars and trucks. Musk hopes the mix will help him establish the first fully-autonomous, self-driving vehicles ever. It's absolutely nothing except the automobile market's Holy Grail. As you know, electrical vehicles and self-driving car stocks have actually been huge this year, however the Wall Street machine has been huge on buzz without much concrete result. In spite of an extreme boost in competition over the past couple of years, Brown still thinks Musk has the best opportunity of putting everything together.
tech could be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Vehicle, and it could be the future of transport. Basically, this innovation would allow you to rent out your automobile as a self-governing, self-driving taxi when you're not utilizing it. You merely leave the cars and truck and press a button on an app that informs the automobile to "join the fleet." Next thing you understand, you're relaxing on your sofa while your automobile shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the revenues. It sounds insane, but it might be closed than you think.